Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma

Journal of Surgical Oncology

Volumn 67, Issue 2, 1998, Pages 90-98

  Wang, Liang Shun ^a   Lin, Hsiao Yi ^a   Chang, Chun Ju ^a   Fahn, Huei Jyh ^a   Huang, Min Hsiung ^a   Lin, Chien Fu Jeff ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Esophageal carcinoma; Esophagectomy; Nutrition and immune status

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN; INTERLEUKIN 2; IRON; TRANSFERRIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; IRON BLOOD LEVEL; NUTRITIONAL STATUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CHOLESTEROL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IRON; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; SERUM ALBUMIN; TRACE ELEMENTS; TRANSFERRIN;

EID: 0031912613     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199802)67:2<90::AID-JSO4>3.0.CO;2-G     Document Type: Article

References (31)

1. Wang PT, Chien KY: Surgical treatment of carcinoma of the esophagus and cardia among the Chinese. Ann Thorac Surg 1983; 35:143-151.
2. Wang LS, Huang MH, Huang BS, Chien KY: Gastric substitution for resectable carcinoma of the esophagus: An analysis of 368 cases. Ann Thorac Surg 1992;53:289-294.
3. Fahn HJ, Wang LS, Huang BS, Huang MH, Chien KY: Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 1994;57:677-681.
4. Skinner DB, Belsay RHR: Management of esophageal disease. In: "Preoperative Evaluation, Staging, and Selection of Treatment for Esophageal Cancer." Philadelphia: WB Saunders, 1988. p 736-763.
5. Akiyama H: Surgery for cancer of the esophagus. "Squamous cell Carcinoma of the Thoracic Esophagus." Baltimore: Williams and Wilkens, 1990, p 19-133.
6. Wang LS, Huang MS, Lin TS, Huang BS, Huang MH, Chien KY: A right thoracotomy approach with en bloc esophagectomy for carcinoma of intrathoracic esophagus - a preliminary report. J Surg Associ ROC 1991;24:829-834.
7. Wong J: Methods available to assess the quality of surgical resection. In: Giuli R (ed) "Proceedings, First Polydisciplinary International Congress," OESO. Paris: Maloine, 1984, p 198-199.
8. Müller JM, Erasmi H, Stelzner M, Zieren U: Surgical therapy of esophageal carcinoma. Br J Surg 1990;77:845-857.
9. Peracchia A, Fumagalli U, Segalin A, Bonavina L: Congress issue-state of the art: Pathogenesis, diagnosis and treatment of cancer of the tubular esophagus. Diseases of the Esophagus 1985;8: 167-174.
10. Baba M, Aikou T, Yoshinaka H, et al.: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Annals Surg 1994;219:310-316.
11. Saito T, Shimoda K, Shigemitsu Y, et al.: Complications of infection and immunologic status after surgery for patients with esophageal cancer. J Surg Oncol 1991;48:21-27.
12. Saito T, Kuwahara A, Shimoda K, et al.: Enhanced immunoglobulin levels correlate with infectious complications after surgery in esophageal cancer. J Surg Oncol 1981;46:3-8.
13. Hennessy TPJ: Lymph node dissection. World J Surg 1994;18: 367-372.
14. International Union Against Cancer: TNM Classification of Malignant Tumors, rev. ed. New York: Springer-Verlag, 1987.
15. Burtis CA, Ashwood ER: "Tietz Textbook of Clinical Chemistry." Philadelphia: Saunders, 1986, p 695-698.
16. Faulkner WR, Meites S: "Selected Methods of Clinical Chemistry," Vol. 9. Washington, DC: AACC, 1982, p 365-373.
17. Lennard TW, Shenton BK, Borzotta A, et al.: The influence of surgical operations on components of the human immune system. Br J Surg 1985;72:771-776.
18. Lukomska B, Olszewski WL, Engeset A, Kolstad P: The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer. Cancer 1983;51:465-469.
19. Hansbrough JF, Bender EM, Zapata-Sirvent R, Anderson J: Altered helper and suppressor lymphocyte populations in surgical patients. Am J Surg 1984;148:303-307.
20. Tsutsui S, Morita M, Kuwano H, et al.: Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol 1992;49:176-181.
21. Miller GC, Pritchard DJ, Ritts RE, Ivins JC, Dierre RV: Effect of surgery on the quality of lymphocyte subpopulations. JJ Surg Res 1976;21:144-148.
22. Wanebo HJ, Jun MY, Strong E, Oettgen HF: T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 1975;130:445.
23. Salsbury AJ, McKinna JA, Griffiths JD, Naunton D, Morgan C: Circulating cancer cells during excision of carcinomas of the rectum and colon with high ligation of the inferior mesenteric vein. Surg Gynecol Obstet 1965;120:1266-1270.
24. Umpleby HC, Fermor B, Symes MO, Wiliamson RCN: Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659-663.
25. Roberts S, Long L, Jonasson O, et al.: The isolation of cancer cells from the blood Stream during uterine curettage. Surg Gynecol Obstet 1960;111:3-11.
26. Watkins SM: The effects of surgery on lymphocyte transformation in patients with cancer. Clin Exp Immunol 1973;14:69-76.
27. Watkins SM: Cancer prognosis predicted by preoperative lymphocyte responsiveness, in vitro. Br J Surg 1976;63:433-437.
28. Haffejee AA, Angorn IM: Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma. Ann Surg 1978;189:475-479.
29. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH: Management of patients with advanced T5 epidermoid carcinoma of the esophagus. J Surg Oncol 1996;62:22-29.
30. Haffejee AA, Angorn IB, Brain PP, Duursma J, Baker LW: Diminished cellular immune due to impaired nutrition in oesophageal carcinoma. Br J Surg 1978;65:480-482.
31. Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ: Effect of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. Cancer Chemother Rep 1974;58:257.